Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 细胞技术

细胞技术

Immunological and Gene Therapy for Ovarian Cancer A Technical Overview

2025-03-14 细胞技术 加入收藏
Conventional medical approaches are limited in part on the prognosis of ovarian

Conventional medical approaches are limited in part on the prognosis of ovarian cancer. Although the advent of platinum- and taxane-based combination chemotherapy represents a significant advance in the treatment of ovarian carcinoma, the 5-yr survival of patients with intraperitoneal (ip) disseminated disease remains poor at only 30-40% (1 -3 ). The vast majority of patients present with disease that is advanced because of transcoelomic spread yet remains locoregionally contained, rather than truly metastatic to distant sites by blood or lymphatic spread.

文章底部广告位

文章评论

加载中~